Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

All GLG News Analyses Filed Under: Business of Medicine

Articles with lock require a GLG News subscription
Posted May 27, 2008
manufacturing not up to GMP
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
The Chinese government funded many manufacturing plants for biologics about 15 years ago, and many are bankrupt because of noninforced patent laws
Posted May 27, 2008
Head to Head Comparisons will Help Patients but Hurt Profits
Analysis of: Warning over drug trial’s effects on testing | www.ft.com
Author: GLG Member Program Contributor
Direct comparisons between potential competing agents often do not exist Initial FDA approval is usually based on comparisons to placebo A new approval does necessarily mean that the new agent is better than existing ones, although this is implied by industry Industry bears all the costs of efficacy...
Posted May 23, 2008
safety concern with chinese drugs
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
How can safety be verified with the Chinese history of contaminants in the toy and food industries.  I certainly would not want to take Chinese drugs. lynn tucker
Posted May 23, 2008
How to Make Two Hospitals as Good as One
Analysis of: Like Night and Day--Shedding Light on Off-Hours Care | content.nejm.org
Author: GLG Member Program Contributor
Although sharing the same address, the hospital from 7 a.m. to 7 p.m. Monday through Friday is a very different hospital during the other 108 hours of the week.  The weekday hospital has a full administrative team, department chairs and service chiefs, experienced nurse managers, and a full complement...
Posted May 22, 2008
China's Full Scale Entry into the Generics Industry
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
China is already a key supplier for many of the current generics in the Western marketplace today either supplying intermediates or the finished pharmaceutical bulk product.  They are where India was ten to twenty years ago. Now with a better appreciation and experience with FDA and EMEA regulatory...
Posted May 22, 2008
Lead In Toys/Contaminated Heparin vs Lower Cost Drugs!
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
Any finished medication that a Chinese company tries to bring to the US (or European) market will face tremendous scrutiny.  Look for Indian generic manufacturers (e.g. Ranbaxy, Dr Reddy's) to maintain their competitive edge due to their track record of safety.  Eventually, lower cost generics...
John Ansell Posted May 21, 2008
Chinese generics is nothing new
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: John Ansell, Director John Ansell Consultancy
In 1976, sitting in my office in International Marketing at Fisons, Loughborough, UK, I used to watch the drums of bulk paracetamol arriving at the factory from China - easily recognizable from the Chinese script decorating them. I'm sure the UK wasn't the only country importing raw materials from China...
Posted May 21, 2008
Xenophobia and Valid Fears: Chinese comestibles and US Health
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
Until Chinese regulations and enforcement catch up with Western consumer standards, the market for Chinese pharmaceuticals will be greatly diminished by its reputation.
Posted May 20, 2008
Big CATTs and catching pharma by the tail.
Analysis of: Warning over drug trial’s effects on testing | www.ft.com
Author: GLG Member Program Contributor
1. Goverment, insurers and other payors will undermine investment in new indications if it saves money. 2. Their next direction will be to fund biogeneric and other innovator altneratives. 3. Companies developing high value line extensions must consider formulation management and other strategies...
Posted May 20, 2008
Chinese Generics?? You must be kidding!
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
Low cost generics to be produced in China will lower drug costs.
Previous Page : 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Next201 to 210 of 648

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-05T01:45:24.617